Cargando…
Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
BACKGROUND: Immunocompromised patients have an increased risk of developing severe COVID disease, as well as a tendency to suboptimal responses to vaccines. The objective of this study was to evaluate the specific cellular and humoral adaptive immune responses of a cohort of kidney transplant recipi...
Autores principales: | Pérez-Flores, Isabel, Juarez, Ignacio, Aiffil Meneses, Arianne S., Lopez-Gomez, Ana, Romero, Natividad Calvo, Rodriguez-Cubillo, Beatriz, Moreno de la Higuera, María Angeles, Peix-Jiménez, Belen, Gonzalez-Garcia, Raquel, Baos-Muñoz, Elvira, Vilela, Ana Arribi, Gómez Del Moral, Manuel, Martínez-Naves, Eduardo, Sanchez-Fructuoso, Ana Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931894/ https://www.ncbi.nlm.nih.gov/pubmed/36817489 http://dx.doi.org/10.3389/fimmu.2023.1111569 |
Ejemplares similares
-
Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022) -
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022) -
Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022) -
Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster
por: Singh, Arminder, et al.
Publicado: (2022) -
Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)